ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In a multivariate analysis, ASXL1 mutation was the only independent risk factor associated with worse EFS in chronic phase CML with a hazard ratio of 4.25 (95% CI 1.59–11.35, P = 0.004).